Hemodialysis & Peritoneal Dialysis Market to 2024 - Growing Preference for Home Hemodialysis (HHD) Treatment

News provided by

Jul 15, 2019, 15:15 ET

DUBLIN, July 15, 2019 /PRNewswire/ -- The "Hemodialysis & Peritoneal Dialysis Market by Product (Machines, Dialyzers, Concentrates, Dialysates, Catheters) Services, Modality (Conventional, CAPD, Nocturnal), End User - Global Forecasts to 2024" report has been added to ResearchAndMarkets.com's offering.

The Hemodialysis and Peritoneal Dialysis Market is Projected to reach USD 99.2 billion by 2024 from USD 74.2 billion in 2019, at a CAGR of 6.0%

Dialysis is a blood purification procedure used primarily as an artificial replacement for lost kidney function in case of kidney failure. It is the most preferred treatment for end-stage renal disease (ESRD). The growing prevalence of diabetes and hypertension has increased the number of ESRD patients worldwide, thus driving the demand for dialysis, globally.

Growth in this market is driven by the increasing number of ESRD patients, growing prevalence of diabetes & hypertension, shortage of organ donors and risks associated with transplant, technological advancements, and initiatives taken by leading players to introduce advanced products & services in the market. However, a number of product recalls and the risks & complications associated with dialysis are restraining the growth of this market to a certain extent.

In this report, the hemodialysis & peritoneal dialysis market is segmented on the basis of product & service, modality, usage, and region.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Hemodialysis & Peritoneal Dialysis: Market Overview
4.2 Hemodialysis & Peritoneal Dialysis Market Share, By Type, 2019 vs 2024
4.3 Hemodialysis Market, By Product & Service, 2019 vs 2024 (USD Billion)
4.4 Hemodialysis Market, By Modality, 2019 vs 2024 (USD Billion)
4.5 Peritoneal Dialysis Market, By Product, 2019 vs 2024 (USD Billion)
4.6 Peritoneal Dialysis Market, By Modality, 2019 vs 2024 (USD Billion)
4.7 Regional Analysis: Hemodialysis & Peritoneal Dialysis Market, By Usage
4.8 Hemodialysis & Peritoneal Dialysis Market, By Country

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number of ESRD Patients
5.2.1.2 Growing Prevalence of Diabetes and Hypertension
5.2.1.3 Shortage of Organ Donors and Risks Associated With Transplant
5.2.1.4 Technological Advancements and New Product Launches
5.2.1.5 Rising R&D Expenditure for Developing New Dialysis Products
5.2.2 Restraints
5.2.2.1 Risks and Complications Associated With Dialysis
5.2.2.2 Product Recalls
5.2.2.3 Reimbursement Concerns in Emerging Markets
5.2.2.4 Stringent Regulatory Policies for the Approval and Manufacturing of Dialysis Products
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Development of User-Friendly and Low-Cost Dialysis Products
5.2.3.3 Increasing Number of Dialysis Centers
5.2.3.4 Growing Preference for Home Hemodialysis (HHD) Treatment
5.2.4 Challenges
5.2.4.1 Benefits of Renal Transplantation
5.2.4.1.1 Low-Cost Solution
5.2.4.1.2 Better Patient Survival Rate
5.2.4.2 Sustainability of Small and Medium-Sized Companies in the Highly Competitive Market
5.3 Industry Trends
5.3.1 Focus on Wearable and Miniature Dialysis Machines
5.3.2 Consolidation of the Dialysis Services Market
5.3.3 Partnerships Among Dialysis Product and Service Providers
5.3.4 Robust Private Equity Activity
5.3.5 Increasing Preference for Private Dialysis Providers
5.4 Reimbursement Scenario
5.5 Regulatory Landscape

6 Hemodialysis Market
6.1 Hemodialysis Market, By Products & Services
6.1.1 Introduction
6.1.2 Hemodialysis Services
6.1.2.1 In-Center Hemodialysis Services
6.1.2.1.1 Growth in Patient Base and Support for Treatment are Driving the Demand for In-Center Services
6.1.2.2 Home Hemodialysis Services
6.1.2.2.1 Poor Reimbursement Scenario for HHD has Hindered Market Growth
6.1.3 Hemodialysis Products
6.1.3.1 Hemodialysis Machines
6.1.3.1.1 Center-Use Hemodialysis Machines
6.1.3.1.1.1 Increasing Number of Renal Care Centers has Ensured A Steady Demand for Center-Use Machines
6.1.3.1.2 Home-Use Hemodialysis Machines
6.1.3.1.2.1 HHD Machines have Gained Significance Due to Their Improved Clinical Outcomes & Better Quality of Life for Patients
6.1.3.2 Hemodialysis Consumables & Supplies
6.1.3.2.1 Dialyzers
6.1.3.2.2 Dialyzers Market, By Material Type
6.1.3.2.2.1 Synthetic Dialyzers
6.1.3.2.2.1.1 Ease of Sterilization, High Strength, and Resistance of Synthetic Dialyzers Account for Their Wide Use
6.1.3.2.2.2 Cellulose-Based Dialyzers
6.1.3.2.2.2.1 High Biocompatibility and Affordability have Enabled Market Growth
6.1.3.2.3 Dialyzers Market, By Flux Type
6.1.3.2.3.1 High-Flux Dialyzers
6.1.3.2.3.1.1 High-Flux Dialyzers Can Clear Medium-Sized Molecules and Prevent the Removal of Proteins From the Blood
6.1.3.2.3.2 Low-Flux Dialyzers
6.1.3.2.3.2.1 Capability to Remove Smaller-Sized Molecules have Made Low-Flux Dialyzers Popular
6.1.3.2.4 Bloodlines
6.1.3.2.4.1 Bloodline Reuse in Emerging Markets is A Key Challenge to the Growth of This Segment
6.1.3.2.5 Concentrates/Dialysates
6.1.3.2.5.1 Maintaining the Quality of Concentrates is A Key Challenge for Market Players
6.1.3.2.6 Access Products
6.1.3.2.6.1 AV Fistula Needles
6.1.3.2.6.1.1 AV Fistula Access Provides Better Blood Flow and Lower Risk of Infections
6.1.3.2.6.2 Arteriovenous Grafts
6.1.3.2.6.2.1 Synthetic AV Grafts are More Widely Used Than Their Biological Counterparts Are
6.1.3.2.6.3 Central Venous Catheters
6.1.3.2.6.3.1 Catheters Can Be Used in the Long Term If Grafts and Fistulas are Unsuccessful
6.1.3.2.7 Other Hemodialysis Consumables
6.2 Hemodialysis Market, By Modality
6.2.1 Conventional Long-Term Hemodialysis
6.2.1.1 Technological Advancements and Rising Number of Dialysis Centers are Driving Market Growth
6.2.2 Short Daily Hemodialysis
6.2.2.1 Daily HD has Demonstrated Better Outcomes Than Conventional HD
6.2.3 Nocturnal Hemodialysis
6.2.3.1 Rising Awareness Will Drive Demand for NHD in the Coming Years
6.3 Water Treatment Systems Market, By Type
6.3.1 Central Water Disinfection Systems
6.3.1.1 Chemical Disinfection Systems
6.3.1.1.1 Chemical Disinfection Systems Segment to Dominate the Central Water Disinfection Systems Market During the Forecast Period
6.3.1.2 Heat Disinfection Systems
6.3.1.2.1 Heat Disinfection Lowers the Labor Costs and Disposal Issues Associated With Disinfection Using Chemicals
6.3.1.3 Accessories
6.3.2 Portable Water Disinfection Systems
6.3.2.1 Chemical Disinfection Systems
6.3.2.1.1 Development of New Ozone Disinfection Systems With High Safety and Efficacy Profiles to Drive Market Growth
6.3.2.2 Heat Disinfection Systems
6.3.2.2.1 Launch of Advanced Portable Heat Disinfection Systems to Drive Market Growth
6.3.2.3 Accessories

7 Peritoneal Dialysis Market
7.1 Peritoneal Dialysis Market, By Product & Service
7.1.1 Introduction
7.1.2 Products
7.1.2.1 Peritoneal Dialysis Concentrates/Dialysates
7.1.2.1.1 High Demand for PD Concentrates has Prompted Players to Focus on Improving Their Manufacturing Capabilities for PD Products
7.1.2.2 Peritoneal Dialysis Machines
7.1.2.2.1 Emerging Countries are Witnessing Growing Adoption of Home Peritoneal Dialysis Treatments
7.1.2.3 Peritoneal Dialysis Catheters
7.1.2.3.1 Development of New Approaches for PD Catheter Placement is Driving Their Adoption
7.1.2.4 Peritoneal Dialysis Transfer Sets
7.1.2.4.1 Baxter International and Fresenius Medical Care are the Major Providers of PD Transfer Sets
7.1.2.5 Other Peritoneal Dialysis Products
7.1.3 Peritoneal Dialysis Services
7.1.3.1 Self-Administrative Nature of PD Leading to the Slow Growth of the Services Market
7.2 Peritoneal Dialysis Market, By Modality
7.2.1 Continuous Ambulatory Peritoneal Dialysis
7.2.1.1 Capd Offers A Wide Range of Advantages Over APD
7.2.2 Automated Peritoneal Dialysis
7.2.2.1 Risk of Rapid Decline in Residual Renal Functions With APD to Limit Its Adoption

8 Hemodialysis & Peritoneal Dialysis Market, By Usage
8.1 Introduction
8.2 In-Center Dialysis
8.2.1 Hospital Dialysis
8.2.1.1 Increasing Government Support to Develop Dialysis Treatment Facilities in Hospitals to Propel the Growth of This Market Segment
8.2.2 Independent Dialysis
8.2.2.1 Changing Reimbursement Policies in Developed Countries and A Scarcity of Skilled Nephrologists are Key Restraints for Market Growth
8.3 Home Dialysis
8.3.1 Peritoneal Dialysis
8.3.1.1 Technological Improvements, Freedom for Patients to Travel During Treatment, and Fewer Dietary Restrictions are Driving the Growth of the Peritoneal Dialysis Market
8.3.2 Home Hemodialysis (HHD)
8.3.2.1 Advantages Such as A Higher Dose of Dialysis, Improved Quality of Life, and Better Clinical Outcomes are Majorly Responsible for the Growing Demand for HHD Among Patients

9 Hemodialysis and Peritoneal Dialysis Market, By Region

10 Competitive Landscape
10.1 Introduction
10.2 Market Share Analysis, By Key Player, 2018
10.2.1 Key Players in the Hemodialysis Products Market
10.2.2 Key Players in the Dialysis Services Market
10.2.3 Key Players in the Peritoneal Dialysis Products Market
10.3 Competitive Situation and Trends
10.3.1 Product Launches and Approvals
10.3.2 Expansions
10.3.3 Mergers & Acquisitions
10.3.4 Partnerships, Agreements, and Collaborations
10.4 Vendor Dive Overview
10.5 Vendor Inclusion Criteria
10.6 Vendor Dive
10.6.1 Visionary Leaders
10.6.2 Innovators
10.6.3 Dynamic Differentiators
10.6.4 Emerging Companies
10.7 Competitive Intensity: Dialysis Products Market
10.7.1 Evaluation Parameters and Scores
10.7.2 Scoring Methodology
10.7.3 Competitive Intensity Score, By Company
10.7.3.1 Fresenius Medical Care AG & Co. KGaA
10.7.3.2 Baxter International, Inc.
10.7.3.3 B. Braun Melsungen Ag
10.7.4 Competitive Intensity - Mapping of Baxter, B. Braun, and Fresenius

11 Company Profiles
11.1 Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
11.2 Baxter International Inc.
11.3 B. Braun Melsungen AG
11.4 Becton, Dickinson and Company
11.5 Cantel Medical Corporation
11.6 Davita Inc.
11.7 Diaverum
11.8 Dialife Group
11.9 Fresenius Medical Care AG & Co. KGaA
11.10 Isopure Corp
11.11 Medtronic PLC
11.12 Nipro Corporation
11.13 NIKKISO Co., Ltd.
11.14 Rockwell Medical, Inc.
11.15 Toray Medical Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/tuzgz5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets